Liu, Yanxin, Changjiang Dong, Xucheng He, Yamin Shu, Pan Wu, and Jian Zou. 2022. “Post-Marketing Safety of Vemurafenib: A Real-World Pharmacovigilance Study of the FDA Adverse Event Reporting System”. Journal of Pharmacy & Pharmaceutical Sciences 25 (December):377-90. https://doi.org/10.18433/jpps33020.